Keywords
uterine fibroids; dyslipidemia; metabolic endocrine diseases; metabolic syndrome
Abstract
The review is devoted to the role of metabolic syndrome in the development of good-quality hyperplastic myometrial lesion. Obesity is a potent potentiating endocrine factor in uterine diseases. Modern correction of endocrine-metabolic disorders is a key component of complex treatment and prevention of hyperplastic diseases of the uterus.